Medrx Co.,Ltd. 4586Short Interest
Estimated short interest in Medrx Co.,Ltd. (4586) is 6.15% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: Barclays Capital Securities Ltd, Mizuho Securities Co., Ltd., Nomura International plc and 1 others.
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It excludes 3 institutions whose last report is more than a year old (2.92% in total). It also excludes 16 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2017-08-30 |
|---|---|
| Latest disclosure | 2026-11-17 (Morgan Stanley MUFG Securities Co., Ltd., 0.42%) |
| Reporting institutions | 25 firms (4326 reports) |
| Peak estimated short interest | 17.07% (2025-09-29, 6 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Barclays Capital Securities Ltd
- Mizuho Securities Co., Ltd.
- Nomura International plc
- Citigroup Global Markets Limited
- JPM Securities Japan Co Ltd.
- Others
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-11-06 | Barclays Capital Securities Ltd | Position 1,658,100 shares | Ratio 2.32% | ▲0.34% | Holding |
| 2026-11-13 | Mizuho Securities Co., Ltd. | Position 1,565,300 shares | Ratio 2.23% | ▲0.77% | Holding |
| 2017-11-06 | JPMorgan Securities Japan Co., Ltd. | Position 125,900 shares | Ratio 1.47% | ▲0.16% | No report for 1+ year |
| 2026-11-16 | Nomura International plc | Position 795,400 shares | Ratio 1.09% | ▲0.10% | Holding |
| 2020-04-24 | Airain Ltd | Position 134,500 shares | Ratio 0.84% | ▲0.45% | No report for 1+ year |
| 2023-12-08 | BNP Paribas Arbitrage SNC | Position 235,800 shares | Ratio 0.61% | ▲0.03% | No report for 1+ year |
| 2026-11-13 | Citigroup Global Markets Limited | Position 375,300 shares | Ratio 0.51% | ▲0.07% | Holding |
| 2026-11-16 | JPM Securities Japan Co Ltd. | Position 357,600 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2024-01-23 | BNP Paribas Financial Markets SNC formerly known as BNP Paribas Arbitrage SNC | Position 189,400 shares | Ratio 0.49% | ▼0.47% | Below 0.5% |
| 2026-02-27 | BNP Paribas Financial Markets SNC | Position 296,400 shares | Ratio 0.49% | ▼0.10% | Below 0.5% |
| 2019-05-30 | PDT Partners, LLC | Position 60,900 shares | Ratio 0.47% | ▼0.04% | Below 0.5% |
| 2026-05-01 | GOLDMAN SACHS INTERNATIONAL | Position 284,664 shares | Ratio 0.47% | ▼0.11% | Below 0.5% |
| 2025-12-22 | UBS AG | Position 280,400 shares | Ratio 0.47% | ▼0.05% | Below 0.5% |
| 2025-01-17 | XTX Markets Pte Ltd | Position 226,700 shares | Ratio 0.47% | ▼0.04% | Below 0.5% |
| 2019-01-04 | OXAM QUANT FUND LIMITED | Position 42,500 shares | Ratio 0.42% | ▼0.11% | Below 0.5% |
| 2025-11-06 | MERRILL LYNCH INTERNATIONAL | Position 251,600 shares | Ratio 0.42% | ▼0.08% | Below 0.5% |
| 2026-11-17 | Morgan Stanley MUFG Securities Co., Ltd. | Position 298,622 shares | Ratio 0.42% | ▼0.17% | Below 0.5% |
| 2026-11-13 | Morgan Stanley & Co. International plc | Position 286,500 shares | Ratio 0.40% | ▼0.18% | Below 0.5% |
| 2019-10-04 | Credit Suisse Securities (Japan) Limited | Position 43,000 shares | Ratio 0.33% | ▼0.30% | Below 0.5% |
| 2023-02-10 | JANE STREET GLOBAL TRADING, LLC | Position 94,400 shares | Ratio 0.30% | ▼0.35% | Below 0.5% |
| 2022-10-05 | Credit Suisse AG | Position 84,200 shares | Ratio 0.30% | ▼0.21% | Below 0.5% |
| 2019-07-08 | Societe Generale | Position 33,700 shares | Ratio 0.26% | ▼0.41% | Below 0.5% |
| 2019-11-22 | Credit Suisse Securities (Europe) Limited | Position 13,100 shares | Ratio 0.10% | ▼0.47% | Below 0.5% |
| 2021-01-18 | Deutsche Bank Aktiengesellschaft, London | Position 0 shares | Ratio 0.00% | ▼1.49% | Closed |
| 2025-08-25 | Macquarie Bank Limited | Position 0 shares | Ratio 0.00% | ▼0.84% | Closed |
Disclosure History 4326 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-17 | Morgan Stanley MUFG Securities Co., Ltd. | Position 298,622 shares | Ratio 0.42% | ▼0.17% | Below 0.5% |
| 2026-11-16 | Nomura International plc | Position 795,400 shares | Ratio 1.09% | ▲0.10% | — |
| 2026-11-16 | JPM Securities Japan Co Ltd. | Position 357,600 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2026-11-13 | Nomura International plc | Position 722,800 shares | Ratio 0.99% | ▼0.05% | — |
| 2026-11-13 | Citigroup Global Markets Limited | Position 375,300 shares | Ratio 0.51% | ▲0.07% | — |
| 2026-11-13 | Mizuho Securities Co., Ltd. | Position 1,565,300 shares | Ratio 2.23% | ▲0.77% | — |
| 2026-11-13 | Morgan Stanley & Co. International plc | Position 286,500 shares | Ratio 0.40% | ▼0.18% | Below 0.5% |
| 2026-11-12 | Morgan Stanley MUFG Securities Co., Ltd. | Position 413,722 shares | Ratio 0.59% | ▼0.02% | — |
| 2026-11-12 | Mizuho Securities Co., Ltd. | Position 1,028,400 shares | Ratio 1.46% | ▲0.24% | — |
| 2026-11-11 | Mizuho Securities Co., Ltd. | Position 860,400 shares | Ratio 1.22% | ▲0.39% | — |
| 2026-11-10 | Morgan Stanley MUFG Securities Co., Ltd. | Position 428,222 shares | Ratio 0.61% | ▲0.03% | — |
| 2026-11-10 | Mizuho Securities Co., Ltd. | Position 587,400 shares | Ratio 0.83% | ▲0.30% | — |
| 2026-11-09 | Morgan Stanley MUFG Securities Co., Ltd. | Position 409,722 shares | Ratio 0.58% | ▼0.05% | — |
| 2026-11-06 | Barclays Capital Securities Ltd | Position 1,658,100 shares | Ratio 2.32% | ▲0.34% | — |
| 2026-11-06 | Morgan Stanley MUFG Securities Co., Ltd. | Position 447,022 shares | Ratio 0.63% | ▼0.16% | — |
| 2026-11-05 | Barclays Capital Securities Ltd | Position 1,416,700 shares | Ratio 1.98% | ▼0.08% | — |
| 2026-11-05 | Morgan Stanley & Co. International plc | Position 412,900 shares | Ratio 0.58% | ▼0.02% | — |
| 2026-11-04 | Morgan Stanley & Co. International plc | Position 420,700 shares | Ratio 0.60% | ▼0.14% | — |
| 2026-11-04 | Barclays Capital Securities Ltd | Position 1,471,200 shares | Ratio 2.06% | ▼0.16% | — |
| 2026-11-02 | Barclays Capital Securities Ltd | Position 1,588,800 shares | Ratio 2.22% | ▼0.17% | — |
| 2026-11-02 | Morgan Stanley MUFG Securities Co., Ltd. | Position 558,822 shares | Ratio 0.79% | ▼0.05% | — |
| 2026-11-02 | Morgan Stanley & Co. International plc | Position 520,100 shares | Ratio 0.74% | ▲0.14% | — |
| 2026-10-29 | Nomura International plc | Position 734,100 shares | Ratio 1.04% | ▼0.24% | — |
| 2026-10-29 | Barclays Capital Securities Ltd | Position 1,674,300 shares | Ratio 2.39% | ▼0.02% | — |
| 2026-10-29 | Morgan Stanley MUFG Securities Co., Ltd. | Position 588,822 shares | Ratio 0.84% | ▲0.06% | — |
| 2026-10-29 | Morgan Stanley & Co. International plc | Position 421,700 shares | Ratio 0.60% | ▲0.15% | — |
| 2026-10-28 | Morgan Stanley MUFG Securities Co., Ltd. | Position 552,022 shares | Ratio 0.78% | ▼0.06% | — |
| 2026-10-27 | Nomura International plc | Position 897,100 shares | Ratio 1.28% | ▼0.06% | — |
| 2026-10-27 | Morgan Stanley & Co. International plc | Position 320,000 shares | Ratio 0.45% | ▼0.05% | Below 0.5% |
| 2026-10-26 | Morgan Stanley & Co. International plc | Position 352,200 shares | Ratio 0.50% | ▲0.01% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| Otsuka Holdings Co.,Ltd.4578 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Large70 |
| RaQualia Pharma Inc.4579 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| SymBio Pharmaceuticals Limited4582 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Chiome Bioscience Inc.4583 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kidswell Bio Corporation4584 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| PeptiDream Inc.4587 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| Oncolys BioPharma Inc.4588 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| RIBOMIC Inc.4591 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| SanBio Company Limited4592 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| HEALIOS K.K.4593 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |